Healthcare Robotics September 2026 Update: What Changed, Why It Matters, and What to Watch Next

September 2026 brought new FDA authorizations, wider robotic-surgery competition, and evidence that still demands careful interpretation.

September 2026 brought new FDA authorizations, wider robotic-surgery competition, and evidence that still demands careful interpretation.

MBOT, the ticker symbol for Microbot Medical Inc., represents one of the more audacious gambles in the healthcare robotics sector""a micro-cap company...

Omnicell stock represents one of the most focused investment opportunities in the healthcare robotics sector, offering exposure to a company that has...

Comprehensive guide to surgical robots and their growing adoption in operating rooms worldwide. Learn how systems like da Vinci work, their clinical benefits, applications across specialties, and the future of robotic surgery.